Sharekhan is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 2675 in its research report dated November 24, 2021.

IPCA Labs: Domestic beat offsets API weakness

The key near-term challenge for IPCA is with respect to API sales. The company expects a softer Q3 due to the supply disruption in Sartan APIs and elevated raw material prices

Buy Ipca Laboratories; target of Rs 2450: Prabhudas Lilladher

Prabhudas Lilladher is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 2450 in its research report dated November 17, 2021.

Buy Ipca Laboratories: target of Rs 2850: Sharekhan

Sharekhan is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 2850 in its research report dated September 09, 2021.

Buy Ipca Laboratories; target of Rs 2560: ICICI Direct

ICICI Direct is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 2560 in its research report dated August 07, 2021.

IPCA Labs: Strong revival for domestic formulations

IPCA, which was mainly known a few years ago for anti-malarial medications, is now having a significant contribution from non-anti-malarial medicines

Accumulate Ipca Laboratories target of Rs 2163: Prabhudas Lilladher

Prabhudas Lilladher recommended accumulate rating on Ipca Laboratories with a target price of Rs 2163 in its research report dated June 01, 2021.

IPCA Labs: Strong margins to sustain even post-COVID opportunities

In spite of the extraordinary sales of Hydroxychloroquine in FY21, IPCA Labs expects a 9-10 per cent growth in topline for FY22

Buy Ipca Laboratories; target of Rs 2400: Motilal Oswal

Motilal Oswal is bullish on Ipca Laboratories recommended buy rating on the stock with a target price of Rs 2400 in its research report dated May 31, 2021.

Buy Ipca Laboratories: target of Rs 2560: Sharekhan

Sharekhan is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 2560 in its research report dated May 31, 2021.

Buy Ipca Laboratories; target of Rs 2480: Motilal Oswal

Motilal Oswal is bullish on Ipca Laboratories recommended buy rating on the stock with a target price of Rs 2480 in its research report dated April 11, 2021.

Buy Ipca Laboratories: target of Rs 2560: Sharekhan

Sharekhan is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 2560 in its research report dated March 18, 2021.

Buy Ipca Laboratories; target of Rs 2490: ICICI Direct

ICICI Direct is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 2490 in its research report dated February 05, 2021.

IPCA Labs: API capacity constraint almost out of the way

IPCA continues to strive for vertical integration of its formulation production to the level of KSM (Key Starting Material). As of now, more than 60 percent of APIs used for formulations are produced in-house

Weekly Tactical Pick: IPCA Labs – Outperforms in domestic formulations market

Ipca's domestic secondary sales are about 12 percent for the quarter gone by. This is in line with management’s guidance for H2 FY21

Buy Ipca Laboratories; target of Rs 2680: Motilal Oswal

Motilal Oswal is bullish on Ipca Laboratories recommended buy rating on the stock with a target price of Rs 2680 in its research report dated November 09, 2020.

Buy Ipca Laboratories: target of Rs 2665: ICICI Direct

ICICI Direct is bullish on Ipca Laboratories recommended buy rating on the stock with a target price of Rs 2665 in its research report dated November 09, 2020.

Hold Ipca Laboratories; target of Rs 2393: Prabhudas Lilladher

Prabhudas Lilladher recommended Hold rating on Ipca Laboratories with a target price of Rs 2393 in its research report dated November 10, 2020.

Accumulate IPCA Laboratories; target of Rs 2369: Dolat Capital Market

Dolat Capital Market recommended accumulate rating on IPCA Laboratories with a target price of Rs 2369 in its research report dated November 09, 2020.

Buy Ipca Laboratories: target of Rs 2560: Sharekhan

Sharekhan is bullish on Ipca Laboratories recommended buy rating on the stock with a target price of Rs 2560 in its research report dated November 09, 2020.

IPCA Labs: Is vaccine anti-thesis to the pharma rally?

A key surprise is the IPCA's confidence in sustenance of EBITDA margin of 25-26 percent in H2 FY21 on the back of both subdued raw material prices and cost-saving measures

Buy IPCA Labs; target of Rs 2300: Anand Rathi

Anand Rathi is bullish on IPCA Labs has recommended buy rating on the stock with a target price of Rs 2300 in its research report dated August 12, 2020.

Buy Ipca Laboratories; target of Rs 2420: Motilal Oswal

Motilal Oswal is bullish on Ipca Laboratories recommended buy rating on the stock with a target price of Rs 2420 in its research report dated August 11, 2020.

Hold Ipca Laboratories; target of Rs 1962: Prabhudas Lilladher

Prabhudas Lilladher recommended Hold rating on Ipca Laboratories with a target price of Rs 1962 in its research report dated August 12, 2020.

Buy Ipca Laboratories; target of Rs 2365: Sharekhan

Sharekhan is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 2365 in its research report dated August 11, 2020.